Nuclear Export Inhibitor class drugs
1 result
Xpovio (selinexor)
(selinexor)Karyopharm Therapeutics Inc.
Usage: XPOVIO is indicated for treating adult patients with multiple myeloma who have received prior therapy, in combination with bortezomib and dexamethasone, or with dexamethasone alone for relapsed/refractory cases. It is also indicated for relapsed/refractory diffuse large B-cell lymphoma after at least two prior treatments.